Designed proteins assemble antibodies into modular nanocages
Robby Divine,Ha V Dang,George Ueda,Jorge A Fallas,Ivan Vulovic,William Sheffler,Shally Saini,Yan Ting Zhao,Infencia Xavier Raj,Peter A Morawski,Madeleine F Jennewein,Leah J Homad,Yu-Hsin Wan,Marti R Tooley,Franziska Seeger,Ali Etemadi,Mitchell L Fahning,James Lazarovits,Alex Roederer,Alexandra C Walls,Lance Stewart,Mohammadali Mazloomi,Neil P King,Daniel J Campbell,Andrew T McGuire,Leonidas Stamatatos,Hannele Ruohola-Baker,Julie Mathieu,David Veesler,David Baker,Ha V. Dang,Jorge A. Fallas,Peter A. Morawski,Madeleine F. Jennewein,Leah J. Homad,Marti R. Tooley,Mitchell L. Fahning,Alexandra C. Walls,Neil P. King,Daniel J. Campbell,Andrew T. McGuire
DOI: https://doi.org/10.1126/science.abd9994
IF: 56.9
2021-04-02
Science
Abstract:Integrating form and function for design Antibodies are broadly used in therapies and as research tools because they can be generated against a wide range of targets. Efficacy can often be increased by clustering antibodies in multivalent assemblies. Divine et al. designed antibody nanocages from two components: One is an antibody-binding homo-oligomic protein and the other is the antibody itself. Computationally designed proteins drive the assembly of antibody nanocages in a range of architectures, allowing control of the symmetry and the antibody valency. The multivalent display enhances antibody-dependent signaling, and nanocages displaying antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein effectively neutralize pseudovirus. Science , this issue p. eabd9994
multidisciplinary sciences